// App-Quantinova.ai

: Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Researchers

Presenter

  • Krzysztof Kalwak

Principal Investigators

  • Jan Styczynski

  • Bernd Gruhn

  • Katharine Patrick

  • Petr Sedlacek

  • Daniel Stachel

  • Karl-Walter Sykora

  • Selim Corbacioglu

  • Katarzyna Drabko

  • Franca Fagioli

  • Johann Greil

  • Franco Locatelli

  • Ingo Mller

  • Bernhard Kremens

  • Paul G. Schlegel

  • Jolanta Gozdzik

  • Birgit Burkhardt

  • Monika Mielcarek-Siedziuk

  • Ajay Vora

Medical Centers

  • Pediatric Hematology/Oncology and BMT,Wroclaw Medical University,Wroclaw,Poland

  • Hospital for Children and Adolescents; Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, Frankfurt, Germany

  • Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

  • Department of Pediatrics, Jena University Hospital, Jena, Germany

  • Sheffied Childrens Hospital, Sheffield, UK

  • Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic,

  • Children's Hospital, University of Erlangen, Erlangen, DEU

  • University Children's Hospital, Tubingen, Germany

  • Internal Medicine III, Department of Hematology, Oncology and Stem Cell Transplantation, University Hospital Regensburg, Regensburg, Germany

  • Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin,

  • Children's Hospital Regina Margherita, University of Turin, Turin, Italy

  • University Children's Hospital of Heidelberg, Germany.

  • IRCCS Ospedale Pediatrico Bambino Gesu, Rome, ITA

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department of Pediatrics III,University Children's Hospital Essen,Essen,Germany

  • University Childrens Hospital Freiburg, Freiburg, Germany

  • Jagiellonian University, Krakow, Poland

  • University Children's Hospital Muenster, Münster, DEU

  • Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

  • Department of Pediatric Anesthesiology, Great Ormond Street Hospital,NHS, London, United Kingdom

Locations

  • Poland

  • Germany

  • Czech Republic

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Hematological malignancies

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Ovastat

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Prospective

Phase

  • II

Study Id's

  • NCT02333058

Sponsors

  • medac GmbH

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved